Keywords: celexa, drives, growth, forest, labs, laboratories, posted
Celexa drives growth at Forest Labs
Article | 06 May 2002
Forest Laboratories has posted a 35% increase in sales for its fiscalfourth quarter ended March 31, 2002, to $436.8 million, driven by a 52% climb ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
